Stem cell transplantation: supportive care and long-term complications

Hematology Am Soc Hematol Educ Program. 2002;422-44. doi: 10.1182/asheducation-2002.1.422.


With increasing hematopoietic stem cell transplant (HSCT) activity and improvement in outcomes, there are many thousands of HSCT survivors currently being followed by non-transplant clinicians for their healthcare. Several types of late sequelae from HSCT have been noted, and awareness of these complications is important in minimizing late morbidity and mortality. Late effects can include toxicities from the treatment regimen, infections from immunodeficiency, endocrine disturbances, growth impairment, psychosocial adjustment disorders, second malignancies, and chronic graft-versus-host disease (GVHD). A variety of risk factors for these complications have been noted. The clinician should be alert to the potential for these health issues. Preventive and treatment strategies can minimize morbidity from these problems and optimize outcomes.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Follow-Up Studies
  • Graft vs Host Disease* / diagnosis
  • Graft vs Host Disease* / etiology
  • Graft vs Host Disease* / therapy
  • Hematologic Diseases / complications
  • Hematologic Diseases / therapy
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Neoplasms, Second Primary / etiology*
  • Neoplasms, Second Primary / pathology
  • Survivors*
  • Transplantation Conditioning / adverse effects